Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Teva
Julphar
Chinese Patent Office
Cipla
Merck
US Army
Baxter
Argus Health

Generated: May 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017058

« Back to Dashboard

NDA 017058 describes METHADONE HYDROCHLORIDE, which is a drug marketed by Vistapharm, West-ward Pharms Int, Akorn, Mylan Institutional, Mallinckrodt Inc, Sandoz, Specgx Llc, Aurolife Pharma Llc, Epic Pharma Llc, Roxane, Sun Pharm Industries, and The Pharmanetwork, and is included in twenty-one NDAs. It is available from seventeen suppliers. Additional details are available on the METHADONE HYDROCHLORIDE profile page.

The generic ingredient in METHADONE HYDROCHLORIDE is methadone hydrochloride. There are thirteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the methadone hydrochloride profile page.
Summary for 017058
Tradename:METHADONE HYDROCHLORIDE
Applicant:West-ward Pharms Int
Ingredient:methadone hydrochloride
Patents:0
Therapeutic Class:Analgesics
Formulation / Manufacturing:see details
Pharmacology for NDA: 017058
Mechanism of ActionFull Opioid Agonists
Medical Subject Heading (MeSH) Categories for 017058
Suppliers and Packaging for NDA: 017058
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METHADONE HYDROCHLORIDE methadone hydrochloride TABLET, FOR SUSPENSION;ORAL 017058 NDA West-Ward Pharmaceuticals Corp. 0054-4538 N 0054-4538-25

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, FOR SUSPENSION;ORALStrength40MG
Approval Date:Approved Prior to Jan 1, 1982TE:AARLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Julphar
Daiichi Sankyo
UBS
QuintilesIMS
Express Scripts
Boehringer Ingelheim
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.